作者
Melissa Yuen, Stephanie L Gianturco, Laura L Pavlech, Kathena D Storm, SeJeong Yoon, Ashlee N Mattingly
发表日期
2020
简介
Benzocaine was nominated for various indications: While the exact medical condition for which the compounded product is being requested is generally unknown, benzocaine is generally used as a local anesthetic. Benzocaine will be compounded as various topical dosage forms and strengths based on the prescriber’s request; the therapeutic dose is 20%. Benzocaine will also be compounded as a topical oral gel in concentrations ranging from 5-20% for use as a numbing agent for local pain relief. Additionally, benzocaine will be compounded as a 20% topical cream for use as a topical anesthetic prior to painful skin procedures. Benzocaine will also be compounded in various dosage forms for topical, vaginal, rectal, oral, and otic use in concentrations ranging from 0.47%-30% to reduce pain caused by minor skin irritations, sore throat, sunburn, teething pain, vaginal or rectal irritation, ingrown toenails, hemorrhoids, ear pain, and other sources of minor pain on a surface of the body. Lastly, benzocaine will be compounded as a topical 20% solution for use as a local anesthetic.
引用总数
学术搜索中的文章
MV Yuen, SL Gianturco, LL Pavlech, KD Storm… - 2020